No abstract

Baipás gástrico de una sola anastomosis (BAGUA) en pacientes con IMC < 30 kg/m2 y diabetes mellitus de tipo 2 (DM2) One-anastomosis gastric bypass (OAGB) in patients with BMI < 30 kg/m2 and diabetes mellitus type 2 (DM2) 10.20960/nh.03545 OR 3545 One-anastomosis gastric bypass (OAGB) in patients with BMI < 30 kg/m 2 and diabetes mellitus type 2 (DM2) Baipás gástrico de una sola anastomosis (BAGUA) en pacientes con IMC < 30 kg/m 2 y diabetes mellitus de tipo 2 (DM2)

The term Metabolic Syndrome (MS) has been used since its introduction in 2001 by the National Cholesterol Program (NCEP: ATP III). The concept has been discussed in the scientific literature for decades. The X Syndrome and other terms such as &quot;death quartet&quot; and insulin resistance syndrome have been used to describe the association between metabolic and cardiovascular risk factors. In Mexico, the prevalence of MS in the National Health and Nutrition Survey (Encuesta Nacional de Salud y Nutrición, ENSANUT) was 34% in 2000 and 41% in 2012. Lifestyle modifications along with increased physical activity, quitting smoking, and limiting alcohol consumption are essential for management and prevention because they play a central role in metabolic abnormalities. However, despite the large amount of medications available for diabetes, up to 50% of patients have been reported to fail to achieve adequate control goals, as defined by the American Diabetes Association (glycosylated hemoglobin &lt;7%). In contrast, bariatric surgery (BS) has clearly confirmed that it contributes to improved beta cell function in patients with BMI &gt; 35 kg / m 2 , as well as control of dyslipidemia and other metabolic disorders. Keywords: Metabolic surgery; surgery and metabolic syndrome; syndrome X; mini gastric bypass; bypass of an anastomosis; Roux-en-Y bypass; bariatric surgery.